600 patients66,869 observations120 daysLIVE

Patient P-01470

Synthetic patientNBL-101 · Day 112 · 25–34 · F · baseline S16Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Unstable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
59%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S16
  2. Day 83 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 83.

Primary contributors, last 14 days
  • Toxicity+17
  • Treatment adherence-7
  • GI instability-5
  • Inflammatory activity+4
  • Nutritional resilience-2

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    66%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 83% showed improvement
    • median effect visible after 8 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    GI burden
    Companion
    58.1/100
    improving · -6.8 vs previous 14 d
    Toxicity
    Blood
    65/100
    worsening · +5.7 vs previous 14 d
    Sleep quality
    Wearable
    12.8/100
    improving · +0.9 vs previous 14 d
    Energy level
    Daily log
    1.8/10
    stable · +0.0 vs previous 14 d
    Stress level
    Daily log
    6.7/10
    stable · +0.1 vs previous 14 d
    Steps
    Wearable
    1,796
    improving · +320 vs previous 14 d
    Adherence
    Companion
    70.4 %
    worsening · -14.7 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 32 from the failing basin, 63 from restoration.

    Would help
    • GI-04 GI Support Protocol
      73% improved among 124 similar · onset 8 d · confidence 65%
    • ME-01 Monitoring Escalation
      100% improved among 77 similar · onset 3 d · confidence 71%
    • NP-02 Dietary Support Protocol
      63% improved among 64 similar · onset 10 d · confidence 71%
    Would not help
    • Keep fat low
      GI +6.6 next day on high-intake days · n 26
    • Keep histamine low
      GI +5.9 next day on high-intake days · n 22
    • Keep simple carbs low
      GI +5.5 next day on high-intake days · n 20
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Dietary fat load
      +6.6detractor · 95%
    • Histamine load
      +5.9detractor · 95%
    • Simple carbohydrates
      +5.5detractor · 95%
    • Alcohol
      -2.3no signal · 39%
    • Insoluble fibre
      +0.5no signal · 15%
    • Spicy / capsaicin
      +0.4no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 90
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 58 and rising
      • WearableSleep 5.4 h, below personal baseline
    • Butyrate / short-chain fatty acid production 80
      • MicrobiomeButyrate capacity 36/100
      • MicrobiomeF. prausnitzii depleted
      • Daily logFibre intake low in recent food logs
    • Autonomic recovery 65
      • WearableResting HR 74 bpm
      • Wearable1,796 steps/day
      • WearableShort sleep window
    • Inflammatory signalling 60
      • MicrobiomeBacteroides fragilis expansion
      • BloodInflammatory load index 65
      • WearableHRV 38 ms, trending down
    • Drug metabolism and exposure 20
      • BloodToxicity index 65
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.2 · butyrate capacity 36/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    38 ms
    Sleep
    5.6 h
    Steps
    2,331
    Resting HR
    72 bpm
    Daily log: GI score 58, nutritional resilience 37, adherence 70.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0181921%S1372
    P-0160421%S0171
    P-0138621%S1370
    P-0135222%S2070
    P-0175021%S1669
    P-0169938%S04GI-04improved69
    P-0150821%S1868
    P-0175421%S1468
    P-0150923%S1768
    P-0181721%S1467
    P-0187738%S01CR-01improved67
    P-0151521%S1666